Search

Search Constraints

You searched for: Author/Creator Roodman G. David guestEditor.

Search Results

10. First‐in‐Asian Phase I Study of the Anti‐Fibroblast Growth Factor 23 Monoclonal Antibody, Burosumab: Safety and Pharmacodynamics in Adults With X‐linked Hypophosphatemia. (14th September 2018)